

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.62561352 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.42983557 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.42983557 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.34084334 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.24908483 |
| 6 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.12761093 |
| 7 | leukocyte aggregation (GO:0070486) | 3.83415526 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.75302067 |
| 9 | detection of other organism (GO:0098543) | 3.70914053 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.64853721 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.64853721 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 3.64853721 |
| 13 | positive regulation by symbiont of host defense response (GO:0052509) | 3.64853721 |
| 14 | modulation by symbiont of host defense response (GO:0052031) | 3.64853721 |
| 15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.64853721 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.51916341 |
| 17 | detection of bacterium (GO:0016045) | 3.50087696 |
| 18 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.41766580 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 3.40715223 |
| 20 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.36985405 |
| 21 | cellular extravasation (GO:0045123) | 3.35300693 |
| 22 | negative thymic T cell selection (GO:0045060) | 3.34620517 |
| 23 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.33057821 |
| 24 | positive thymic T cell selection (GO:0045059) | 3.32960404 |
| 25 | negative T cell selection (GO:0043383) | 3.28358252 |
| 26 | regulation of gamma-delta T cell activation (GO:0046643) | 3.25532377 |
| 27 | protein localization to endosome (GO:0036010) | 3.25049410 |
| 28 | negative regulation of cell killing (GO:0031342) | 3.19576640 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.19576640 |
| 30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.14183063 |
| 31 | detection of external biotic stimulus (GO:0098581) | 3.13656471 |
| 32 | tolerance induction (GO:0002507) | 3.07432855 |
| 33 | regulation of B cell differentiation (GO:0045577) | 3.07360923 |
| 34 | cell adhesion mediated by integrin (GO:0033627) | 3.05305057 |
| 35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.03726629 |
| 36 | detection of molecule of bacterial origin (GO:0032490) | 3.02130173 |
| 37 | positive regulation of interferon-alpha production (GO:0032727) | 3.01176568 |
| 38 | regulation of leukocyte degranulation (GO:0043300) | 2.96992547 |
| 39 | regulation of T cell tolerance induction (GO:0002664) | 2.96963118 |
| 40 | regulation of mast cell degranulation (GO:0043304) | 2.96788102 |
| 41 | barbed-end actin filament capping (GO:0051016) | 2.95851753 |
| 42 | B cell receptor signaling pathway (GO:0050853) | 2.95460556 |
| 43 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.95122153 |
| 44 | regulation of interferon-alpha production (GO:0032647) | 2.90974244 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 2.90582210 |
| 46 | T cell migration (GO:0072678) | 2.88025916 |
| 47 | * leukocyte cell-cell adhesion (GO:0007159) | 2.85135727 |
| 48 | response to muramyl dipeptide (GO:0032495) | 2.85099697 |
| 49 | negative regulation of T cell mediated immunity (GO:0002710) | 2.84881748 |
| 50 | germinal center formation (GO:0002467) | 2.84319069 |
| 51 | negative regulation of phagocytosis (GO:0050765) | 2.83919055 |
| 52 | positive regulation of B cell differentiation (GO:0045579) | 2.82364516 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.82120714 |
| 54 | thymic T cell selection (GO:0045061) | 2.81207628 |
| 55 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.80667748 |
| 56 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.80484195 |
| 57 | cellular response to zinc ion (GO:0071294) | 2.77880237 |
| 58 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.77400753 |
| 59 | neutrophil activation (GO:0042119) | 2.77311631 |
| 60 | detection of biotic stimulus (GO:0009595) | 2.75870659 |
| 61 | hepatocyte apoptotic process (GO:0097284) | 2.75547526 |
| 62 | pinocytosis (GO:0006907) | 2.74844797 |
| 63 | positive regulation of lamellipodium assembly (GO:0010592) | 2.74789205 |
| 64 | response to laminar fluid shear stress (GO:0034616) | 2.74735444 |
| 65 | response to interleukin-15 (GO:0070672) | 2.74447531 |
| 66 | NIK/NF-kappaB signaling (GO:0038061) | 2.74298381 |
| 67 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.72719529 |
| 68 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.70705511 |
| 69 | cellular response to interleukin-15 (GO:0071350) | 2.70493628 |
| 70 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.69512190 |
| 71 | granulocyte activation (GO:0036230) | 2.68855327 |
| 72 | negative regulation of interleukin-12 production (GO:0032695) | 2.68688186 |
| 73 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.67639007 |
| 74 | hypotonic response (GO:0006971) | 2.67255505 |
| 75 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.66321797 |
| 76 | positive regulation of macrophage differentiation (GO:0045651) | 2.64358226 |
| 77 | regulation of necroptotic process (GO:0060544) | 2.61861003 |
| 78 | macrophage activation involved in immune response (GO:0002281) | 2.61554732 |
| 79 | substrate-dependent cell migration (GO:0006929) | 2.61405853 |
| 80 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.60287470 |
| 81 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.60089394 |
| 82 | morphogenesis of an endothelium (GO:0003159) | 2.59092956 |
| 83 | endothelial tube morphogenesis (GO:0061154) | 2.59092956 |
| 84 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.59031344 |
| 85 | response to peptidoglycan (GO:0032494) | 2.58762490 |
| 86 | myeloid dendritic cell activation (GO:0001773) | 2.58756682 |
| 87 | stress fiber assembly (GO:0043149) | 2.58536418 |
| 88 | positive regulation of isotype switching (GO:0045830) | 2.57316459 |
| 89 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.57017027 |
| 90 | response to type I interferon (GO:0034340) | 2.56913398 |
| 91 | regulation of macrophage cytokine production (GO:0010935) | 2.55059696 |
| 92 | T cell selection (GO:0045058) | 2.54331464 |
| 93 | actin nucleation (GO:0045010) | 2.53619908 |
| 94 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.53323449 |
| 95 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.53269517 |
| 96 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.53269517 |
| 97 | myeloid dendritic cell differentiation (GO:0043011) | 2.52639462 |
| 98 | heterotypic cell-cell adhesion (GO:0034113) | 2.51491748 |
| 99 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.51137042 |
| 100 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.51084315 |
| 101 | T cell costimulation (GO:0031295) | 2.50859291 |
| 102 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.50816128 |
| 103 | cellular response to type I interferon (GO:0071357) | 2.50616453 |
| 104 | type I interferon signaling pathway (GO:0060337) | 2.50616453 |
| 105 | regulation of tolerance induction (GO:0002643) | 2.49735523 |
| 106 | positive regulation of interferon-beta production (GO:0032728) | 2.49685296 |
| 107 | macrophage activation (GO:0042116) | 2.49091975 |
| 108 | interferon-gamma production (GO:0032609) | 2.47770538 |
| 109 | positive regulation of tolerance induction (GO:0002645) | 2.47346540 |
| 110 | positive T cell selection (GO:0043368) | 2.46169302 |
| 111 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.45877234 |
| 112 | natural killer cell differentiation (GO:0001779) | 2.45031079 |
| 113 | lymphocyte costimulation (GO:0031294) | 2.44754121 |
| 114 | positive regulation of lamellipodium organization (GO:1902745) | 2.43999712 |
| 115 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.43597621 |
| 116 | angiogenesis involved in wound healing (GO:0060055) | 2.42937036 |
| 117 | germ cell migration (GO:0008354) | 2.42617925 |
| 118 | respiratory burst (GO:0045730) | 2.42118526 |
| 119 | defense response to protozoan (GO:0042832) | 2.41915688 |
| 120 | mannose metabolic process (GO:0006013) | 2.41612298 |
| 121 | B cell mediated immunity (GO:0019724) | 2.41473413 |
| 122 | negative regulation of B cell proliferation (GO:0030889) | 2.40794739 |
| 123 | megakaryocyte development (GO:0035855) | 2.39537623 |
| 124 | myeloid cell activation involved in immune response (GO:0002275) | 2.39410548 |
| 125 | regulation of defense response to virus by virus (GO:0050690) | 2.39354284 |
| 126 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.38641339 |
| 127 | response to host immune response (GO:0052572) | 2.38457396 |
| 128 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.38457396 |
| 129 | membrane raft organization (GO:0031579) | 2.37547845 |
| 130 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.37099806 |
| 131 | response to host (GO:0075136) | 2.37099806 |
| 132 | response to host defenses (GO:0052200) | 2.37099806 |
| 133 | regulation of response to interferon-gamma (GO:0060330) | 2.36241310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.14425093 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.30686073 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.16655500 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.16472463 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.73212429 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.64380071 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.45211623 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.23806051 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.00962991 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.78347862 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.78208585 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.78084662 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.72329492 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70764263 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65611792 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.61292626 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.47243566 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.35303479 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.34052090 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.33546770 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.26274314 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.25316021 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.24557504 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21827514 |
| 25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20983626 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.06718849 |
| 27 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.05106229 |
| 28 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.03382545 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 1.95054589 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94191721 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.92016984 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.91745561 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91525589 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90641088 |
| 35 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.87057631 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.85765380 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.84321050 |
| 38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81113338 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.79767987 |
| 40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.76205208 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75568198 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.73846948 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.70118114 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.65186620 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.61663303 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56167447 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.51628629 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51197841 |
| 49 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.48958251 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.48689763 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.48293736 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.48179049 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.47583905 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.45728488 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44302461 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.44055330 |
| 57 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43001867 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40596589 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.36930693 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35516339 |
| 61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.35154918 |
| 62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33881396 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32207902 |
| 64 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29010259 |
| 65 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28775669 |
| 66 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27241923 |
| 67 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.22133515 |
| 68 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.22133515 |
| 69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21277081 |
| 70 | MAF_26560356_Chip-Seq_TH2_Human | 1.20896365 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18093571 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16817404 |
| 73 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16664685 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11688212 |
| 75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11326028 |
| 76 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.11023574 |
| 77 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10935806 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08981580 |
| 79 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08421404 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08173254 |
| 81 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07701712 |
| 82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06861165 |
| 83 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06665933 |
| 84 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04919188 |
| 85 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.04741527 |
| 86 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04351732 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04336324 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03373866 |
| 89 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.01895799 |
| 90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01378367 |
| 91 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01266159 |
| 92 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01188406 |
| 93 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.01006037 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00759861 |
| 95 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.00545064 |
| 96 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97903542 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97267501 |
| 98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95926823 |
| 99 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95143927 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93414541 |
| 101 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92640518 |
| 102 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91620640 |
| 103 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90854057 |
| 104 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90676949 |
| 105 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90346117 |
| 106 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.89131269 |
| 107 | GATA3_26560356_Chip-Seq_TH2_Human | 0.88861474 |
| 108 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88511636 |
| 109 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88376920 |
| 110 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.88367273 |
| 111 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88126544 |
| 112 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87599042 |
| 113 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.87382872 |
| 114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86425309 |
| 115 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84281305 |
| 116 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.82391639 |
| 117 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.82190083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.04896122 |
| 2 | MP0003303_peritoneal_inflammation | 2.80587151 |
| 3 | MP0003436_decreased_susceptibility_to | 2.70539392 |
| 4 | MP0000685_abnormal_immune_system | 2.64239980 |
| 5 | MP0003300_gastrointestinal_ulcer | 2.57823004 |
| 6 | MP0001790_abnormal_immune_system | 2.41939755 |
| 7 | MP0005387_immune_system_phenotype | 2.41939755 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.38120942 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.32519612 |
| 10 | MP0001800_abnormal_humoral_immune | 2.30162966 |
| 11 | MP0005671_abnormal_response_to | 2.25332489 |
| 12 | MP0009785_altered_susceptibility_to | 2.24787753 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.22494874 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.20915232 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.19181257 |
| 16 | MP0002419_abnormal_innate_immunity | 2.10863486 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 2.09332095 |
| 18 | MP0005025_abnormal_response_to | 2.01304525 |
| 19 | MP0002723_abnormal_immune_serum | 2.01024509 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.00887533 |
| 21 | MP0001819_abnormal_immune_cell | 1.99783873 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 1.97935949 |
| 23 | MP0003279_aneurysm | 1.95540014 |
| 24 | MP0005451_abnormal_body_composition | 1.92195738 |
| 25 | MP0004808_abnormal_hematopoietic_stem | 1.91249725 |
| 26 | MP0002396_abnormal_hematopoietic_system | 1.91214368 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.91089753 |
| 28 | MP0009278_abnormal_bone_marrow | 1.90134014 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.87754814 |
| 30 | MP0002405_respiratory_system_inflammati | 1.86210482 |
| 31 | MP0003724_increased_susceptibility_to | 1.84356856 |
| 32 | MP0006054_spinal_hemorrhage | 1.82976350 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.81201023 |
| 34 | MP0002398_abnormal_bone_marrow | 1.80454362 |
| 35 | MP0006082_CNS_inflammation | 1.80073980 |
| 36 | MP0004947_skin_inflammation | 1.74075574 |
| 37 | MP0008260_abnormal_autophagy | 1.73313827 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.70678934 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.70350180 |
| 40 | MP0000858_altered_metastatic_potential | 1.66261307 |
| 41 | MP0003448_altered_tumor_morphology | 1.66061905 |
| 42 | MP0003091_abnormal_cell_migration | 1.65952244 |
| 43 | MP0000716_abnormal_immune_system | 1.64157145 |
| 44 | MP0002006_tumorigenesis | 1.63497596 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.62442738 |
| 46 | MP0005023_abnormal_wound_healing | 1.60872681 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.58642388 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.58301127 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.58301127 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.55188044 |
| 51 | MP0004510_myositis | 1.52257624 |
| 52 | MP0001853_heart_inflammation | 1.51351348 |
| 53 | MP0002933_joint_inflammation | 1.50937058 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.49925636 |
| 55 | MP0001958_emphysema | 1.49157663 |
| 56 | MP0002722_abnormal_immune_system | 1.48256897 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.41691034 |
| 58 | MP0000343_altered_response_to | 1.40883360 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.40354054 |
| 60 | MP0002429_abnormal_blood_cell | 1.39813734 |
| 61 | MP0002877_abnormal_melanocyte_morpholog | 1.37678836 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.25621386 |
| 63 | MP0003950_abnormal_plasma_membrane | 1.24785254 |
| 64 | MP0003828_pulmonary_edema | 1.23528147 |
| 65 | MP0010307_abnormal_tumor_latency | 1.20895913 |
| 66 | MP0001879_abnormal_lymphatic_vessel | 1.20697914 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.19838335 |
| 68 | MP0003045_fibrosis | 1.19536062 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 1.19170793 |
| 70 | MP0000733_abnormal_muscle_development | 1.18282399 |
| 71 | MP0010368_abnormal_lymphatic_system | 1.17494854 |
| 72 | MP0000767_abnormal_smooth_muscle | 1.15872874 |
| 73 | MP0001873_stomach_inflammation | 1.13213784 |
| 74 | MP0004883_abnormal_blood_vessel | 1.12972738 |
| 75 | MP0000569_abnormal_digit_pigmentation | 1.10404869 |
| 76 | MP0003075_altered_response_to | 1.10071871 |
| 77 | MP0005275_abnormal_skin_tensile | 1.05134352 |
| 78 | MP0009840_abnormal_foam_cell | 1.04622701 |
| 79 | MP0005390_skeleton_phenotype | 1.03208785 |
| 80 | MP0000490_abnormal_crypts_of | 1.03197549 |
| 81 | MP0005623_abnormal_meninges_morphology | 1.02939258 |
| 82 | MP0001849_ear_inflammation | 1.01469579 |
| 83 | MP0003172_abnormal_lysosome_physiology | 0.98938178 |
| 84 | MP0001915_intracranial_hemorrhage | 0.98527698 |
| 85 | MP0001851_eye_inflammation | 0.96458394 |
| 86 | MP0000249_abnormal_blood_vessel | 0.94685386 |
| 87 | MP0008469_abnormal_protein_level | 0.93160989 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.89635113 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.87442439 |
| 90 | MP0004272_abnormal_basement_membrane | 0.86832244 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.85758402 |
| 92 | MP0008004_abnormal_stomach_pH | 0.84505215 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.83424990 |
| 94 | MP0009763_increased_sensitivity_to | 0.82400325 |
| 95 | MP0003795_abnormal_bone_structure | 0.82161713 |
| 96 | MP0009764_decreased_sensitivity_to | 0.80822881 |
| 97 | MP0005409_darkened_coat_color | 0.80658609 |
| 98 | MP0000604_amyloidosis | 0.78479468 |
| 99 | MP0005165_increased_susceptibility_to | 0.77087707 |
| 100 | MP0001542_abnormal_bone_strength | 0.76716298 |
| 101 | MP0008007_abnormal_cellular_replicative | 0.76578488 |
| 102 | MP0001243_abnormal_dermal_layer | 0.76161929 |
| 103 | MP0001348_abnormal_lacrimal_gland | 0.74443638 |
| 104 | MP0000015_abnormal_ear_pigmentation | 0.73491762 |
| 105 | MP0005164_abnormal_response_to | 0.73440236 |
| 106 | MP0002925_abnormal_cardiovascular_devel | 0.71003524 |
| 107 | MP0002132_abnormal_respiratory_system | 0.70083185 |
| 108 | MP0002128_abnormal_blood_circulation | 0.69692536 |
| 109 | MP0004381_abnormal_hair_follicle | 0.68875201 |
| 110 | MP0001614_abnormal_blood_vessel | 0.68735170 |
| 111 | MP0005310_abnormal_salivary_gland | 0.68371196 |
| 112 | MP0005503_abnormal_tendon_morphology | 0.66763686 |
| 113 | MP0005621_abnormal_cell_physiology | 0.65820629 |
| 114 | MP0002060_abnormal_skin_morphology | 0.63902804 |
| 115 | MP0005257_abnormal_intraocular_pressure | 0.63658370 |
| 116 | MP0003866_abnormal_defecation | 0.62007457 |
| 117 | MP0005166_decreased_susceptibility_to | 0.61022006 |
| 118 | MP0010630_abnormal_cardiac_muscle | 0.59132870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.22029783 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.16125011 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 3.55339783 |
| 4 | Myositis (HP:0100614) | 3.27452591 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.25932695 |
| 6 | Recurrent fungal infections (HP:0002841) | 3.23150221 |
| 7 | Recurrent viral infections (HP:0004429) | 3.11965225 |
| 8 | Cellulitis (HP:0100658) | 3.10355230 |
| 9 | Interstitial pulmonary disease (HP:0006530) | 3.04307411 |
| 10 | Protrusio acetabuli (HP:0003179) | 3.03400235 |
| 11 | Hematochezia (HP:0002573) | 3.01516334 |
| 12 | Cerebral aneurysm (HP:0004944) | 3.00670126 |
| 13 | Osteolytic defects of the hand bones (HP:0009699) | 2.96085032 |
| 14 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.96085032 |
| 15 | Increased density of long bones (HP:0006392) | 2.92066748 |
| 16 | Spontaneous hematomas (HP:0007420) | 2.87687529 |
| 17 | Aortic aneurysm (HP:0004942) | 2.83840433 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 2.80431693 |
| 19 | Prolonged bleeding time (HP:0003010) | 2.76467187 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 2.75775469 |
| 21 | Chronic otitis media (HP:0000389) | 2.73157212 |
| 22 | Increased IgE level (HP:0003212) | 2.70894267 |
| 23 | Premature rupture of membranes (HP:0001788) | 2.68666090 |
| 24 | Orchitis (HP:0100796) | 2.68335321 |
| 25 | Recurrent bronchitis (HP:0002837) | 2.63959154 |
| 26 | Abnormality of macrophages (HP:0004311) | 2.61935723 |
| 27 | Epistaxis (HP:0000421) | 2.61288205 |
| 28 | Peritonitis (HP:0002586) | 2.58458314 |
| 29 | Abnormality of T cell number (HP:0011839) | 2.57231514 |
| 30 | Abnormality of the nasal mucosa (HP:0000433) | 2.57175317 |
| 31 | T lymphocytopenia (HP:0005403) | 2.54652047 |
| 32 | Syringomyelia (HP:0003396) | 2.53143408 |
| 33 | Spinal cord lesions (HP:0100561) | 2.53143408 |
| 34 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52122041 |
| 35 | Aortic dissection (HP:0002647) | 2.51188662 |
| 36 | Recurrent skin infections (HP:0001581) | 2.50871893 |
| 37 | Dilatation of the ascending aorta (HP:0005111) | 2.47083342 |
| 38 | Pustule (HP:0200039) | 2.45890690 |
| 39 | Gastrointestinal infarctions (HP:0005244) | 2.45611186 |
| 40 | IgM deficiency (HP:0002850) | 2.41418706 |
| 41 | Spondylolisthesis (HP:0003302) | 2.40553110 |
| 42 | Nasal polyposis (HP:0100582) | 2.37380966 |
| 43 | Abnormal platelet volume (HP:0011876) | 2.36797543 |
| 44 | Arterial thrombosis (HP:0004420) | 2.33791197 |
| 45 | Vasculitis (HP:0002633) | 2.33175706 |
| 46 | Obstructive lung disease (HP:0006536) | 2.32082599 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.32082599 |
| 48 | Increased cerebral lipofuscin (HP:0011813) | 2.31170455 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.29352188 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.29352188 |
| 51 | Cervical subluxation (HP:0003308) | 2.28657447 |
| 52 | Osteomyelitis (HP:0002754) | 2.28528584 |
| 53 | Abnormality of glycolipid metabolism (HP:0010969) | 2.28477250 |
| 54 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.28477250 |
| 55 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.28477250 |
| 56 | Thrombocytosis (HP:0001894) | 2.28293878 |
| 57 | Optic neuritis (HP:0100653) | 2.24450039 |
| 58 | Retrobulbar optic neuritis (HP:0100654) | 2.24450039 |
| 59 | Meningitis (HP:0001287) | 2.24106556 |
| 60 | Vertebral compression fractures (HP:0002953) | 2.23827313 |
| 61 | Urticaria (HP:0001025) | 2.21595787 |
| 62 | Polycythemia (HP:0001901) | 2.20699106 |
| 63 | Abnormality of T cells (HP:0002843) | 2.19268524 |
| 64 | Agammaglobulinemia (HP:0004432) | 2.18030016 |
| 65 | Stomatitis (HP:0010280) | 2.16172619 |
| 66 | Petechiae (HP:0000967) | 2.15429127 |
| 67 | Increased mean platelet volume (HP:0011877) | 2.14903861 |
| 68 | Gingival bleeding (HP:0000225) | 2.14726116 |
| 69 | Emphysema (HP:0002097) | 2.13082023 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.12825120 |
| 71 | Leukocytosis (HP:0001974) | 2.11311550 |
| 72 | Gingivitis (HP:0000230) | 2.11214702 |
| 73 | Fatigue (HP:0012378) | 2.10746265 |
| 74 | Periodontitis (HP:0000704) | 2.10448713 |
| 75 | Gastrointestinal inflammation (HP:0004386) | 2.10435909 |
| 76 | Pulmonary infiltrates (HP:0002113) | 2.09910717 |
| 77 | Gastrointestinal stroma tumor (HP:0100723) | 2.09896675 |
| 78 | Abnormal platelet function (HP:0011869) | 2.09436908 |
| 79 | Impaired platelet aggregation (HP:0003540) | 2.09436908 |
| 80 | Verrucae (HP:0200043) | 2.09072810 |
| 81 | Papilloma (HP:0012740) | 2.09072810 |
| 82 | Persistence of primary teeth (HP:0006335) | 2.08277146 |
| 83 | Encephalitis (HP:0002383) | 2.08060762 |
| 84 | Increased connective tissue (HP:0009025) | 2.07633125 |
| 85 | Amyloidosis (HP:0011034) | 2.06772659 |
| 86 | Absent frontal sinuses (HP:0002688) | 2.06735383 |
| 87 | Granulocytopenia (HP:0001913) | 2.06608481 |
| 88 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.06055709 |
| 89 | Myocardial infarction (HP:0001658) | 2.03102644 |
| 90 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.02955011 |
| 91 | Viral hepatitis (HP:0006562) | 2.01258557 |
| 92 | Keratoconjunctivitis sicca (HP:0001097) | 2.00077505 |
| 93 | Distal lower limb amyotrophy (HP:0008944) | 1.99343436 |
| 94 | Colitis (HP:0002583) | 1.98748326 |
| 95 | Lymphopenia (HP:0001888) | 1.98246634 |
| 96 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.96879317 |
| 97 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.95499121 |
| 98 | Mitral valve prolapse (HP:0001634) | 1.94848648 |
| 99 | Shallow orbits (HP:0000586) | 1.92080073 |
| 100 | Loss of speech (HP:0002371) | 1.90998636 |
| 101 | Abnormality of the peritoneum (HP:0002585) | 1.90700478 |
| 102 | Menorrhagia (HP:0000132) | 1.90639578 |
| 103 | Panhypogammaglobulinemia (HP:0003139) | 1.89661780 |
| 104 | Eosinophilia (HP:0001880) | 1.88645041 |
| 105 | Hypergammaglobulinemia (HP:0010702) | 1.87900874 |
| 106 | Vacuolated lymphocytes (HP:0001922) | 1.87444315 |
| 107 | Abnormality of the fingertips (HP:0001211) | 1.86053577 |
| 108 | Aneurysm (HP:0002617) | 1.84249838 |
| 109 | Ankle contracture (HP:0006466) | 1.84170999 |
| 110 | Chest pain (HP:0100749) | 1.84128154 |
| 111 | IgA deficiency (HP:0002720) | 1.83977361 |
| 112 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.83897455 |
| 113 | Disinhibition (HP:0000734) | 1.83744342 |
| 114 | Skin ulcer (HP:0200042) | 1.83685890 |
| 115 | Broad face (HP:0000283) | 1.83685708 |
| 116 | Camptodactyly of toe (HP:0001836) | 1.83665297 |
| 117 | Increased IgM level (HP:0003496) | 1.83366807 |
| 118 | Subacute progressive viral hepatitis (HP:0006572) | 1.82568477 |
| 119 | Abnormality of T cell physiology (HP:0011840) | 1.82359696 |
| 120 | Bicuspid aortic valve (HP:0001647) | 1.82024384 |
| 121 | Increased variability in muscle fiber diameter (HP:0003557) | 1.81837086 |
| 122 | Hypertensive crisis (HP:0100735) | 1.81774843 |
| 123 | Abnormality of oral frenula (HP:0000190) | 1.81572128 |
| 124 | Autoimmune hemolytic anemia (HP:0001890) | 1.78479280 |
| 125 | Purpura (HP:0000979) | 1.78146192 |
| 126 | Ulnar bowing (HP:0003031) | 1.77575544 |
| 127 | Hemoptysis (HP:0002105) | 1.77484032 |
| 128 | Vascular tortuosity (HP:0004948) | 1.76225653 |
| 129 | Glomerulopathy (HP:0100820) | 1.75697655 |
| 130 | Acrocyanosis (HP:0001063) | 1.75090981 |
| 131 | Arterial tortuosity (HP:0005116) | 1.73612930 |
| 132 | Mucosal telangiectasiae (HP:0100579) | 1.71752311 |
| 133 | Dysostosis multiplex (HP:0000943) | 1.71427840 |
| 134 | Restrictive lung disease (HP:0002091) | 1.70130997 |
| 135 | Radial bowing (HP:0002986) | 1.69298008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.70272668 |
| 2 | PRPF4B | 3.62443159 |
| 3 | TRIB3 | 2.57988246 |
| 4 | JAK3 | 2.52902919 |
| 5 | TTN | 2.48021029 |
| 6 | TYK2 | 2.33924136 |
| 7 | MAP3K10 | 2.21382640 |
| 8 | ERN1 | 2.20985421 |
| 9 | MAP3K14 | 2.16098915 |
| 10 | TGFBR2 | 2.13044631 |
| 11 | TBK1 | 2.11014968 |
| 12 | TXK | 2.10279697 |
| 13 | ZAP70 | 2.04728826 |
| 14 | BLK | 1.98225711 |
| 15 | PKN2 | 1.91429996 |
| 16 | RPS6KA4 | 1.88764600 |
| 17 | * STK10 | 1.85597231 |
| 18 | KIT | 1.84344873 |
| 19 | JAK1 | 1.71626118 |
| 20 | ITK | 1.69180799 |
| 21 | EEF2K | 1.64535212 |
| 22 | SMG1 | 1.63786470 |
| 23 | CSK | 1.61392605 |
| 24 | KDR | 1.58584945 |
| 25 | EPHB1 | 1.50685098 |
| 26 | PIM2 | 1.49031860 |
| 27 | IRAK4 | 1.48674721 |
| 28 | BTK | 1.46259957 |
| 29 | CDK12 | 1.42895159 |
| 30 | FGFR3 | 1.41642173 |
| 31 | FGFR4 | 1.41124684 |
| 32 | IKBKE | 1.39335629 |
| 33 | PTK6 | 1.39249139 |
| 34 | TEC | 1.35478610 |
| 35 | HCK | 1.30247247 |
| 36 | IKBKB | 1.29609167 |
| 37 | CSF1R | 1.27420965 |
| 38 | TRPM7 | 1.27398951 |
| 39 | MAP2K3 | 1.25977780 |
| 40 | TAOK2 | 1.22325079 |
| 41 | NEK9 | 1.21187359 |
| 42 | KSR2 | 1.20627818 |
| 43 | TGFBR1 | 1.19630129 |
| 44 | RIPK1 | 1.17591586 |
| 45 | STK3 | 1.17515396 |
| 46 | LCK | 1.14510180 |
| 47 | * LRRK2 | 1.12985118 |
| 48 | MARK3 | 1.08782087 |
| 49 | MAP3K1 | 1.08689831 |
| 50 | FLT3 | 1.08601220 |
| 51 | SYK | 1.08480241 |
| 52 | CDK6 | 1.08397240 |
| 53 | PIM1 | 1.07713398 |
| 54 | TESK1 | 1.06912134 |
| 55 | GRK6 | 1.06037622 |
| 56 | CHUK | 1.06004032 |
| 57 | TESK2 | 1.04097544 |
| 58 | DMPK | 1.02298359 |
| 59 | PAK4 | 1.00358974 |
| 60 | ICK | 0.99355911 |
| 61 | CDC42BPA | 0.92768526 |
| 62 | MAP3K13 | 0.91233196 |
| 63 | BMPR2 | 0.91083774 |
| 64 | PRKD2 | 0.90814234 |
| 65 | RIPK4 | 0.90764737 |
| 66 | IRAK3 | 0.88464968 |
| 67 | CLK1 | 0.86229088 |
| 68 | PDGFRA | 0.86155285 |
| 69 | SIK1 | 0.85267999 |
| 70 | MARK2 | 0.85052533 |
| 71 | EPHA3 | 0.84956883 |
| 72 | MAP3K6 | 0.79613944 |
| 73 | NLK | 0.79418056 |
| 74 | YES1 | 0.78008520 |
| 75 | BMX | 0.77766663 |
| 76 | LYN | 0.77646689 |
| 77 | STK24 | 0.76171382 |
| 78 | PDGFRB | 0.76096130 |
| 79 | TAOK1 | 0.74440698 |
| 80 | PIK3CG | 0.73595360 |
| 81 | PTK2 | 0.70134368 |
| 82 | NME2 | 0.68927889 |
| 83 | TNK2 | 0.66914807 |
| 84 | STK4 | 0.66555006 |
| 85 | MAPK7 | 0.65967533 |
| 86 | MAPKAPK2 | 0.65423800 |
| 87 | CDK4 | 0.64916601 |
| 88 | JAK2 | 0.63616410 |
| 89 | PAK2 | 0.63447882 |
| 90 | PDPK1 | 0.62628832 |
| 91 | MAPK12 | 0.62537613 |
| 92 | MAP3K3 | 0.62349015 |
| 93 | MATK | 0.61696532 |
| 94 | HIPK2 | 0.61532905 |
| 95 | PDK1 | 0.60913219 |
| 96 | DDR2 | 0.57444547 |
| 97 | EGFR | 0.57303951 |
| 98 | MAP3K5 | 0.55099732 |
| 99 | MAP3K7 | 0.55038604 |
| 100 | NEK2 | 0.54138165 |
| 101 | PRKCH | 0.54113152 |
| 102 | MST4 | 0.52613025 |
| 103 | MAPK11 | 0.51290294 |
| 104 | RET | 0.51282925 |
| 105 | IRAK1 | 0.50961211 |
| 106 | ALK | 0.50910349 |
| 107 | MELK | 0.50373244 |
| 108 | MOS | 0.50345496 |
| 109 | CAMK1D | 0.50157097 |
| 110 | PRKG2 | 0.49767877 |
| 111 | ILK | 0.49062653 |
| 112 | RAF1 | 0.46128526 |
| 113 | FES | 0.45978247 |
| 114 | TIE1 | 0.45976147 |
| 115 | STK38 | 0.45755432 |
| 116 | FYN | 0.45347915 |
| 117 | MTOR | 0.45196551 |
| 118 | ABL1 | 0.45168302 |
| 119 | INSR | 0.44791649 |
| 120 | SCYL2 | 0.44633532 |
| 121 | TAOK3 | 0.42037584 |
| 122 | IGF1R | 0.38935094 |
| 123 | RPS6KB2 | 0.38715044 |
| 124 | * MAP3K8 | 0.38150138 |
| 125 | MAP3K11 | 0.35409488 |
| 126 | SIK3 | 0.35207882 |
| 127 | FGFR1 | 0.35161320 |
| 128 | SIK2 | 0.34933155 |
| 129 | PTK2B | 0.34357758 |
| 130 | FGR | 0.33490555 |
| 131 | BRSK2 | 0.32904176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.64735824 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.31508984 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.19261674 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.15259316 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.06273766 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.95005273 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.93089493 |
| 8 | * Measles_Homo sapiens_hsa05162 | 1.89728323 |
| 9 | Viral myocarditis_Homo sapiens_hsa05416 | 1.86502290 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.85679997 |
| 11 | Shigellosis_Homo sapiens_hsa05131 | 1.80362586 |
| 12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.77502336 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76558230 |
| 14 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.76353585 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.71459015 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69946878 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69469485 |
| 18 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.67565898 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.67512439 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.60949383 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59531154 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.58855863 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.57617948 |
| 24 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.57501204 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.56353683 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.54739842 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.51188396 |
| 28 | Apoptosis_Homo sapiens_hsa04210 | 1.51023124 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.48095441 |
| 30 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.46983395 |
| 31 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.44450061 |
| 32 | Allograft rejection_Homo sapiens_hsa05330 | 1.44179608 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.41506976 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.41084953 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.40719208 |
| 36 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.36417877 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.36337887 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34851692 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.33547248 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.32293914 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.27576856 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27070505 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.26421429 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26404149 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.26178272 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.23094130 |
| 47 | Focal adhesion_Homo sapiens_hsa04510 | 1.22749083 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.22256309 |
| 49 | Adherens junction_Homo sapiens_hsa04520 | 1.20590305 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.12807108 |
| 51 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.11867123 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 1.07478923 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.06698019 |
| 54 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.06507698 |
| 55 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.05596138 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05473197 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 1.03924871 |
| 58 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.02486384 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01969692 |
| 60 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.01426652 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 1.01322833 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.96526811 |
| 63 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.95783692 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95357273 |
| 65 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89486685 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.89429368 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86312942 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.86277285 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.86266633 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80731638 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79446802 |
| 72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79177811 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 0.76986188 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73611376 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73049886 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.72901107 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70415661 |
| 78 | Prostate cancer_Homo sapiens_hsa05215 | 0.69127940 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.67263311 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66596976 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65617456 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64341130 |
| 83 | Pathways in cancer_Homo sapiens_hsa05200 | 0.63595083 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62677320 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.62247073 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61155066 |
| 87 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.60060334 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.59961812 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.58685103 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58540286 |
| 91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58070026 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57402374 |
| 93 | Cell cycle_Homo sapiens_hsa04110 | 0.56465828 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55742861 |
| 95 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.55741020 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53573456 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53366551 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52761070 |
| 99 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52630419 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52509097 |
| 101 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51838398 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.51836896 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51597297 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50665525 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48375044 |
| 106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47791084 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.44551940 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44007511 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41506095 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40691808 |
| 111 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.40357133 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40209549 |

